SMI 8'435 1.5%  Dow 17'417 1.3%  Nikkei 17'722 0.7%  Euro 1.0434 -0.2% 
SPI 8'298 1.4%  EStoxx50 3'372 0.4%  Gold 1'261 0.2%  Dollar 0.9200 -0.3% 
DAX 10'738 0.3%  FTSE100 6'811 -0.2%  Öl 49.1 1.4%  Pfund 1.3881 -0.2% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
02.07.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.06.08 Biomarin Pharmaceutical hold Citigroup Corp.
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
29.01.15 Qorvo Buy MKM Partners
29.01.15 Coach Neutral Mizuho
29.01.15 EMC Outperform FBR Capital
29.01.15 Bellatrix Exploration Outperform Northland Capital
29.01.15 Nokia Neutral MKM Partners
29.01.15 Cardinal Health Outperform FBR Capital
29.01.15 Wellpoint Equal weight Barclays Capital
29.01.15 Cirrus Logic overweight Barclays Capital
29.01.15 Commscope overweight Barclays Capital
29.01.15 Facebook overweight Barclays Capital
29.01.15 Peabody Energy Equal weight Barclays Capital
29.01.15 QUALCOMM overweight Barclays Capital
29.01.15 ServiceNow overweight Barclays Capital
29.01.15 JetBlue Airways Market Perform Cowen and Company, LLC
29.01.15 QUALCOMM Buy Argus Research Company
29.01.15 Brinker International Buy Argus Research Company
29.01.15 Check Point Software Technologies Outperform FBR Capital
29.01.15 Energizer Neutral UBS AG
29.01.15 Fortinet Buy UBS AG
29.01.15 International Paper Buy UBS AG
29.01.15 Murphy Oil Neutral UBS AG
29.01.15 Salix Pharmaceuticals Buy UBS AG
29.01.15 ServiceNow Buy UBS AG
29.01.15 TE Connectivity Buy UBS AG
29.01.15 Pinnacle West Capital Neutral UBS AG
29.01.15 QUALCOMM Neutral UBS AG
29.01.15 Penn National Gaming Outperform FBR Capital
29.01.15 Allegiant Travel Buy Deutsche Bank AG
29.01.15 Boeing Buy Deutsche Bank AG
29.01.15 Vertex Pharmaceuticals Buy Deutsche Bank AG
29.01.15 Wellpoint Buy Deutsche Bank AG
29.01.15 AmerisourceBergen Hold Deutsche Bank AG
29.01.15 Radware Buy Dougherty & Company LLC
29.01.15 PulteGroup Neutral Compass Point
29.01.15 Pharmacyclics Buy ROTH Capital Partners, LLC
29.01.15 Flowserve Buy Maxim Group
29.01.15 CACI International Buy Maxim Group
29.01.15 IberiaBank Buy Wunderlich
29.01.15 Huntington Bancshares Hold Miller Tabak
29.01.15 Wacker Chemie Halten Norddeutsche Landesbank (Nord/LB)
29.01.15 JENOPTIK kaufen DZ-Bank AG
29.01.15 LANXESS Halten Bankhaus Lampe KG
29.01.15 Infineon Technologies Hold Commerzbank AG
29.01.15 QIAGEN Underperform BNP PARIBAS
29.01.15 QUALCOMM Buy Canaccord Adams
29.01.15 Hugo Boss Hold Société Générale Group S.A. (SG)
29.01.15 Vodafone Group buy Goldman Sachs Group Inc.
29.01.15 BVB (Borussia Dortmund) buy Close Brothers Seydler Research AG
29.01.15 Capstead Mortgage Hold Wunderlich
29.01.15 Infineon Technologies Hold Hauck & Aufhäuser Privatbankiers KGaA